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The patS gene encodes a small peptide that is required for normal heterocyst pattern formation in the
cyanobacterium Anabaena sp. strain PCC 7120. PatS is proposed to control the heterocyst pattern by lateral
inhibition. patS minigenes were constructed and expressed by different developmentally regulated promoters to
gain further insight into PatS signaling. patS minigenes patS4 to patS8 encode PatS C-terminal 4 (GSGR) to
8 (CDERGSGR) oligopeptides. When expressed by PpetE, PpatS, or PrbcL promoters, patS5 to patS8 inhibited
heterocyst formation but patS4 did not. In contrast to the full-length patS gene, PhepA-patS5 failed to restore a
wild-type pattern in a patS null mutant, indicating that PatS-5 cannot function in cell-to-cell signaling if it is
expressed in proheterocysts. To establish the location of the PatS receptor, PatS-5 was confined within the
cytoplasm as a gfp-patS5 fusion. The green fluorescent protein GFP–PatS-5 fusion protein inhibited heterocyst
formation. Similarly, full-length PatS with a C-terminal hexahistidine tag inhibited heterocyst formation.
These data indicate that the PatS receptor is located in the cytoplasm, which is consistent with recently
published data indicating that HetR is a PatS target. We speculated that overexpression of other Anabaena
strain PCC 7120 RGSGR-encoding genes might show heterocyst inhibition activity. In addition to patS and
hetN, open reading frame (ORF) all3290 and an unannotated ORF, orf77, encode an RGSGR motif. Overex-
pression of all3290 and orf77 under the control of the petE promoter inhibited heterocyst formation, indicating
that the RGSGR motif can inhibit heterocyst development in a variety of contexts.
The regulation of cellular differentiation and pattern forma-
tion are fundamental features of developmental biology that
can be studied in heterocystous cyanobacteria. When com-
bined nitrogen is depleted from the environment, 8 to 10% of
vegetative cells in the filamentous cyanobacterium Anabaena
(Nostoc) sp. strain PCC 7120 differentiate into nitrogen-fixing
heterocysts, which are distributed in a semiregular pattern
along filaments (12, 25, 34). It is clear that cell-to-cell commu-
nication must be involved in the control of heterocyst pattern
formation (6, 11, 35, 37).
The PatS peptide is proposed to control heterocyst pattern
formation by lateral inhibition, such that a diffusible PatS sig-
nal produced by differentiating cells inhibits nearby cells in the
same filament from differentiating (36). In Anabaena strain
PCC 7120, the patS gene contains two potential ATG start
codons and could encode 13- or 17-amino-acid polypeptides
(36). The closely related species Anabaena variabilis contains
an identical patS open reading frame (ORF) at the nucleotide
level. However, the patS ortholog in Nostoc punctiforme lacks
the upstream start codon and contains only 13 codons (26).
patS overexpression inhibits heterocyst formation in Anabaena
strain PCC 7120, and a patS null mutant forms heterocysts in
nitrate-containing medium and forms multiple contiguous het-
erocysts (Mch phenotype) after a nitrogen step-down (36). The
last five carboxy-terminal amino acid residues are important
for the function of patS. Missense mutations affecting these
residues fail to inhibit heterocyst formation, and a synthetic
pentapeptide corresponding to these 5 amino acids (PatS-5,
RGSGR) inhibits heterocyst development at submicromolar
concentrations. A synthetic oligopeptide corresponding to the
last four patS-encoded amino acids (PatS-4, GSGR) has much
lower heterocyst inhibition activity (36).
After nitrogen step-down, wild-type filaments produce about
10% single heterocysts in a semiregular pattern, but a patS null
mutant produces an Mch phenotype with about 30% hetero-
cysts. From these data alone, PatS could either be directly
responsible for producing a normal pattern by lateral inhibi-
tion or be required for a normal response to another, as yet
unidentified, diffusible inhibitor produced by differentiating
cells. This was tested by bathing filaments of a patS mutant
with 60 nM PatS-5 pentapeptide, which reduced the number of
heterocysts to about 10% but failed to restore a normal pattern
(36). This experiment shows that exposure to uniform PatS
concentrations cannot produce a normal pattern. However,
expression of the patS gene from the heterocyst-specific hepA
promoter complemented the patS null mutant and produced a
nearly normal pattern (36). These data suggest that a gradient
of PatS signal originating from differentiating cells is required
to produce a normal pattern.
A patS-gfp transcriptional fusion showed that patS is ex-
pressed early during heterocyst development in differentiating
cells (36, 37). The patS-gfp reporter strain showed that patS
transcription was localized to individual cells or small groups of
cells by 8 to 10 h after the nitrogen step-down. By 12 to 14 h,
bright fluorescence was present in mostly single cells, with a
pattern that resembled the wild-type heterocyst pattern. At
18 h after the nitrogen step-down, the green fluorescent pro-
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tein (GFP) fluorescence was almost exclusively from prohet-
erocysts. The temporal and spatial pattern of patS expression
strongly supports the lateral-inhibition model in which the patS
product, possibly a processed C-terminal peptide, acts as an
intercellular signal produced by differentiating heterocysts to
inhibit the differentiation of neighboring cells. The differenti-
ating PatS-producing cells must themselves be refractory to the
PatS signal (36); however, the mechanism of this immunity to
PatS inhibition is not yet known.
Diffusible signal molecules influence development in several
prokaryotic organisms including Bacillus subtilis, Myxococcus
xanthus, and Streptomyces spp. (17, 20). Receptor molecules for
these signals may be present either outside the cell or within
the cytoplasm. For example, ComX and PhrA are two well-
characterized signal peptides regulating competence and
sporulation in the gram-positive bacterium B. subtilis (13, 27,
28). The receptor for ComX is in the plasma membrane, while
the receptor for PhrA is located inside the cytoplasm. ComX is
a modified peptide pheromone used by B. subtilis to regulate
the transcription of quorum-responsive genes. A 55-amino-
acid ComX precursor is cleaved by ComQ to produce a 10-
amino-acid peptide, which is modified at a tryptophan residue
and exported as an active intercellular signal (1). The ComX
receptor, ComP, is a membrane-bound histidine protein kinase
(30). ComP and the ComA transcription factor form a two-
component system that regulates competence development
(13, 21).
The PhrA precursor is a 44-amino-acid polypeptide that is
processed to produce the C-terminal pentapeptide ARNQT,
which is the active signal (31). In target cells, PhrA pentapep-
tide is imported by the oligopeptide permease system (Opp)
(29). The PhrA receptor, RapA, is a phosphatase located in the
cytoplasm. PhrA pentapeptide inhibits the phosphatase activity
of RapA on Spo0F-P, which is a component of the phosphore-
lay controlling the initiation of sporulation (16, 27, 28).
Lazazzera et al. expressed the active PhrA pentapeptide
inside cells from a minigene to establish that the PhrA receptor
was in the cytoplasm (22). Expression of the phrA minigene
was able to rescue the sporulation defect of a phrA mutant (22,
30). They also used minigenes to study CSF, the competence-
and sporulation-stimulating factor. Expression of a phrC mini-
gene encoding the mature CSF pentapeptide showed that CSF
targets are intracellular (22).
In this study, we used patS minigenes and gene fusions in
Anabaena strain PCC 7120 to show that the PatS receptor is
likely to be located in the cytoplasm and that, unlike the wild-
type PatS signal, the patS5 minigene product cannot function
in cell-to-cell signaling. Our results are consistent with recent
data indicating that HetR is likely to be the PatS receptor (15).
HetR is a key activator of heterocyst development (5) that was
previously shown to be positively autoregulated (2) and to have
autoproteolytic activity (38). Zhao’s laboratory has now shown
that HetR forms a homodimer with DNA-binding activity and
that this DNA-binding activity is inhibited in vitro by synthetic
PatS pentapeptide (15).
MATERIALS AND METHODS
Strains and culture conditions. The strains and plasmids used in this study are
described in Table 1. Anabaena strain PCC 7120 and its derivatives were grown
in BG-11 or BG-110 (which lacks sodium nitrate) medium at 30°C as previously
described (10). For strains containing shuttle plasmids, cultures were supple-
mented with neomycin at 25 g/ml for both liquid and solid media. The patS null
mutant AMC451 (36) and its derivatives were grown in media supplemented with
spectinomycin and streptomycin at 1 g/ml each. For heterocyst inductions,
filaments from actively growing cultures with an optical density at 750 nm of
about 0.3 were collected by centrifugation and washed twice with water before
being transferred to BG-110 as previously described (37).
Escherichia coli strains were maintained in Lennox L broth liquid or agar-
solidified medium. For plasmid preparation, strains were grown in 0.5 TB
liquid medium as described previously (10). E. coli strain DH10B was used for
plasmid maintenance, and the media were supplemented with appropriate anti-
biotics as required.
Copper-inducible expression from the petE promoter. patS minigenes, all3290,
and orf77 were expressed from the copper-inducible petE promoter (PpetE) de-
rived from plasmid pPet1 (5). BG-11 medium, with CuSO4 omitted, was used for
copper-deficient growth conditions. As a precaution to prevent copper contam-
ination, disposable plasticware was used instead of glassware for medium prep-
aration and during the assay (5). All solutions were filter sterilized instead of
being autoclaved. To induce the PpetE promoter, dissolved CuSO4 was added to
copper-deficient BG-11 medium at a final concentration of 0.4 M CuSO4.
For heterocyst induction with or without copper, rapidly growing filaments
from standard BG-11 were collected and washed twice with copper-deficient
BG-110 medium. The filaments were then transferred into plastic culture tubes
containing 3 ml of BG-110 with or without Cu2 or into 24-well tissue culture
plates (Falcon) containing 2 ml of BG-110 with or without Cu2. The cultures
were incubated for 48 h under standard growth conditions. Filaments were
scored for heterocyst frequency; detached heterocysts were not scored (37).
patS minigenes. patS minigenes designated patS4 to patS8 encode PatS C-
terminal oligopeptides from 4 (GSGR) to 8 (CDERGSGR) amino acids, respec-
tively. patS minigenes were expressed from different promoters by being fused to
the native start codon downstream of the promoter sequence (Fig. 1; Table 2).
Each construct was generated by PCR with a forward primer complementary to
the template containing the desired promoter. Each reverse primer consisted of
two parts. The 5 portion encoded the minigenes and a stop codon, and the 3
portion (approximately 17 bases) was complementary to the promoter template
such that the start codon was fused to the minigene sequences. The high-fidelity
Pwo DNA polymerase (Roche) was used in the PCR to generate blunt-end
products.
Plasmid constructions. DNA fragments (500 bp) containing PpetE-patS4 to
PpetE-patS8 minigenes (Fig. 1A) were inserted into pBluescript II SK() at the
EcoRV site, and the BamHI-SmaI fragments from the resulting plasmids were
inserted into conjugal shuttle vector pAM504 (32) at the same sites to produce
plasmids pAM2525, pAM2424, pAM2526, pAM2529, and pAM2527, respec-
tively. The BamHI-digested PCR product PpatS-patS5 (750 bp) (Fig. 1B) was
inserted into pAM504 between BamHI and SmaI sites, resulting in plasmid
pAM2528. The blunt-ended PCR product PrbcL-patS5 (400 bp) (Fig. 1C) was
inserted into the pBluescript II SK() EcoRV site, resulting in pAM2506. The
PvuII fragment containing the PrbcL-patS5 construct from pAM2506 was inserted
into pAM504 at the SmaI site, resulting in plasmid pAM2537. The BamHI-
digested PCR product PhepA-patS5 (800 bp) (Fig. 1D) was inserted into pBlue-
script II SK() between BamHI and EcoRV sites, resulting in plasmid
pAM2811. The SalI DNA fragment containing PhepA-patS5 from pAM2811 was
inserted into the SalI sites of shuttle vectors pAM504 and pAM1956, resulting in
plasmids pAM2814 (PhepA-patS5) and pAM2816 (PhepA-patS5-gfp), respectively.
In pAM2816, gfp is downstream of patS5 as a transcriptional fusion.
PrbcL-gfp-patS5 was generated by PCR with primers AMO-367 and AMO-617
and pAM1954 as the template to produce a translational fusion between gfp and
patS5. The 1.7-kb PCR fragment containing PrbcL-gfp-patS5 was inserted into
pAM504 at the SmaI site, resulting in pAM2873.
A fusion of full-length PatS with a C-terminal His6 tag was constructed in two
cloning steps. First, PCR primers AMO-569 and AMO-583 were used to produce
patS and its upstream sequences with flanking XhoI and SapI sites. The resulting
XhoI-SapI fragment was inserted into pAM2600, resulting in pAM2821, such
that patS is translationally fused to six histidine codons. Second, an XhoI-ClaI
fragment carrying patS-6His from pAM2821 was inserted into shuttle vector
pAM2770 (23), resulting in plasmid pAM2826.
A DNA fragment containing ORF all3290 was produced by PCR with primers
AMO-659 and AMO-660, digested with NdeI and XmaI, and then inserted into
the same sites of pAM2770, resulting in pAM2918, such that all3290 is expressed
by the petE promoter.
A DNA fragment containing ORF orf77 was produced by PCR with primers
AMO-661 and AMO-662, digested with NdeI and XmaI, and then inserted into
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the same sites of pAM2770, resulting in pAM2898, such that orf77 is driven by
the petE promoter.
For all constructs, the ribosome-binding site and start codon were derived
from the promoters used. In all constructs, the inserts were downstream of a
transcription terminator on shuttle vectors pAM504, pAM505, and pAM2770
(23, 32, 36). All plasmid constructs were confirmed by sequencing.
Plasmid conjugations. Shuttle plasmids were transferred into E. coli conjugal
donor strain AM1359 (36) by electroporation and then transferred into
Anabaena strain PCC 7120 by conjugation, using standard methods (8).
Heterocyst inhibition bioassay. A bioassay, similar to that used in previous
work (36), was used in an attempt to detect the presence of heterocyst inhibition
activity in the culture supernatant of a strain overexpressing the patS5 minigene.
A strain carrying PrbcL-patS5 on pAM2537 was grown in BG-110 medium to an
optical density of 0.5 at 750 nm, and then the culture supernatant was collected
after centrifugation at 2,000  g for 7 min at room temperature. The culture
supernatant was filtered through a sterile 0.45-m-pore-size filter. The assay was
performed with 100 l of medium in a 96-well flat-bottom microtiter plate
(Thermo LabSystems). Wild-type Anabaena strain PCC 7120 was used as the test
strain for the heterocyst inhibition assay. Vegetative-cell filaments were grown in
BG-11 medium to an optical density of about 0.3 at 750 nm, harvested by
centrifugation, and washed twice with BG-110 medium. Heterocyst development
was induced by resuspending the filaments in either 100 l of BG-110 medium,
100 l of conditioned culture supernatant, or a 0.5 dilution containing 50 l of
conditioned culture supernatant and 50 l of BG-110 medium. As a positive
control for inhibition, synthetic PatS-5 peptide at 0.1, 0.5, and 1 M was added
to 100 l of both BG-110 medium and conditioned culture supernatant. The
assay plates were incubated under standard conditions for 24 to 48 h, and then
samples were scored microscopically for the frequency of heterocysts as de-
scribed previously (36, 37).
Microscopy and scoring of the heterocyst pattern. Microscopy, image process-
ing, and scoring of the heterocyst pattern were performed as described previously
(36, 37). Three or more samples were scored for each experimental condition.
Images of GFP fluorescence with excitation wavelengths of 450 to 490 nm and
emission wavelengths of 505 to 531 nm were recorded with a Hamamatsu color
charge-coupled device camera.
RESULTS
Suppression of heterocyst development by patS minigenes
driven by a copper-inducible promoter. The patS gene product
is thought to function as an intercellular signal produced by
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Derivation and/or relevant feature(s) Source or reference
Anabaena strains
PCC 7120 Wild type R. Haselkorn
AMC451 patS 36
E. coli strains
DH10B F mcrA (mrr-hsdRMS-mcrBC) 80dlacZM15 lacX74 deoR recA1
endA1 araD139 (ara, leu)7697 galU galK 	 rpsL nupG Smr
GIBCO BRL Life Technologies
AM1359 DH10B containing pRL623 and pRL443; conjugal donor strain 8, 36
Plasmids
pAM504 pDU1-based shuttle vector; Kmr Nmr 32
pAM505 pDU1-based shuttle vector; Kmr Nmr 36
pAM1630 0.9-kb EcoRV-SalI fragment containing PhepA from pRL1905 cloned
in pBluescript II KS(); Apr
This study
pAM1690 PrbcL-patS cloned in pAM504 23
pAM1715 PhepA-patS cloned in pAM504 36
pAM1951 PpatS-gfp cloned in pAM505 36
pAM1954 PrbcL-gfp cloned in pAM504 36
pAM1956 Promoterless gfp in pAM505 36
pAM2269 petE promoter in pAM504 This study
pAM2424 PpetE-patS5 cloned in pAM504 This study
pAM2506 PrbcL-patS5 cloned in pBluescript II SK() This study
pAM2525 PpetE-patS4 cloned in pAM504 This study
pAM2526 PpetE-patS6 cloned in pAM504 This study
pAM2527 PpetE-patS8 cloned in pAM504 This study
pAM2528 PpatS-patS5 cloned in pAM504 This study
pAM2529 PpetE-patS7 cloned in pAM504 This study
pAM2532 PpatS-patS5 cloned in pBluescript II SK() This study
pAM2537 PrbcL-patS5 from pAM2506 cloned in pAM504 This study
pAM2600 SapI-6His-ClaI sequence cloned in pUC18 downstream of lacZ 23
pAM2770 Shuttle vector containing PpetE; Km
r Nmr 23
pAM2811 PhepA-patS5 cloned in pBluescript II SK() This study
pAM2814 0.8-kb SalI fragment containing PhepA-patS5 from pAM2811 cloned in
pAM504
This study
pAM2816 PhepA-patS5 from pAM2811 cloned in pAM1956 to form PhepA-patS5-
gfp transcriptional fusion
This study
pAM2821 668-bp XhoI-SapI PCR fragment containing patS cloned in pAM2600
to form patS-6His
This study
pAM2826 688-bp XhoI-ClaI fragment carrying patS-6His from pAM2821 cloned
in shuttle vector pAM2770
This study
pAM2873 1.7-kb PCR fragment containing PrbcL-gfp-patS5 translational fusion
cloned in pAM504
This study
pAM2898 PpetE-orf77 cloned in shuttle vector pAM2770 This study
pAM2918 PpetE-all3290 cloned in shuttle vector pAM2770 This study
pRL1905 hepA upstream region containing PhepA in pRL487 39
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differentiating cells and possibly mature heterocysts to inhibit
heterocyst formation of neighboring cells by lateral inhibition.
Previous work showed that a full-length patS gene, driven by
the copper-inducible promoter PpetE, suppressed heterocyst
development (36). The PpetE promoter is expressed in vegeta-
tive cells (5) and is down-regulated in heterocysts (7). We
found that a PpetE-gfp transcriptional reporter showed green
fluorescence in both vegetative cells and heterocysts (data not
shown), suggesting that the petE promoter is at least partially
active in heterocysts. In an effort to determine the localization
of the PatS receptor and the characteristics of its interaction
with different PatS C-terminal peptides, we expressed patS
minigenes from the PpetE promoter and measured the hetero-
cyst inhibition activity of the gene products produced in the
cytoplasm of vegetative cells. The patS minigenes contain an
ATG translational start codon followed by sequences encoding
PatS C-terminal oligopeptides from 4 (GSGR) to 8 (CDERG
SGR) amino acids.
Plasmids pAM2525, pAM2424, pAM2526, pAM2529, and
pAM2527 (Table 1), containing the PpetE-patS4 to PpetE-patS8
minigenes (Fig. 1A), respectively, were transferred into wild-
type Anabaena strain PCC 7120 and the patS null mutant strain
AMC451 by conjugation. The resulting strains were induced
for heterocyst formation in copper-replete and copper-defi-
cient conditions. Under copper-replete conditions, wild-type
Anabaena strain PCC 7120 containing PpetE-patS5, PpetE-patS6,
and PpetE-patS8 formed less than 1% heterocysts (Table 3) and
a strain containing PpetE-patS7 formed 4% heterocysts. How-
ever, PpetE-patS4 failed to inhibit heterocyst formation or alter
the heterocyst pattern. Heterocyst formation in the patS null
mutant AMC451 was partially inhibited by minigenes PpetE-
patS5, PpetE-patS6, PpetE-patS7, and PpetE-patS8, with PpetE-
patS5 showing the strongest effect. PpetE-patS4 had no effect on
heterocyst development in AMC451. Even under copper-defi-
cient conditions, PpetE-patS5 to PpetE-patS8 were able to par-
tially inhibit heterocyst formation, indicating that some expres-
sion from the petE promoter was occurring under our
experimental conditions (Table 3). In an attempt to further
deplete copper in the cells, we grew filaments in copper-free
BG-11 medium for several days before induction, but we ob-
PpetE-patS4: AMO-428 (    MGSGR*)
PpetE-patS5: AMO-389 (   MRGSGR*)
PpetE-patS6: AMO-429 (  MERGSGR*)
PpetE-patS7: AMO-430 ( MDERGSGR*)
PpetE-patS8: AMO-431 (MCDERGSGR*)
pAM2269PpetEAMO-388
A
AMO-367 PpatS pAM1951
PpatS-patS5: AMO-432 (MRGSGR*)
B
AMO-367 PrbcL pAM1954
PrbcL-patS5: AMO-421 (MRGSGR*)
C
GTL-T7 PhepA
PhepA-patS5: AMO-557 (MRGSGR*)
pAM1630
D
FIG. 1. Diagram of patS minigene constructs. Each PCR product
results in a promoter upstream region (open arrows) fused at the start
codon to a patS minigene sequence, ending with a UAG stop codon
encoded by the 5 end of the reverse primer. The 3 ends of the reverse
primers are complementary to the promoter template. (A) Construction
of PpetE-patS4 to PpetE-patS8. pAM2269 was used as the PCR template for
PpetE. The forward primer was AMO-388 for all five constructions. The
PatS peptides encoded by the reverse primers are shown. (B) To generate
PpatS-patS5, pAM1951 was used as the PCR template for PpatS and the
patS5 sequence was encoded on the reverse primer AMO-432. AMO-367
was the forward primer. (C) To generate PrbcL-patS5, pAM1954 was used
as the PCR template for PrbcL and the patS5 sequence was encoded on the
reverse primer AMO-421. AMO-367 was the forward primer. (D) To
generate PhepA-patS5, pAM1630 was used as the PCR template for PhepA
and the patS5 sequence was encoded on the reverse primer AMO-557.
GTL-T7 was the forward primer. The closed arrows indicate PCR prim-
ers. *, stop codon. Diagrams are not to scale.
TABLE 2. PCR primer sequences used in this study
Primer Sequencea
GTL-T7.............aatacgactcactatag
AMO-367..........acccgtcgaactgcgcgcta
AMO-369..........cgctctgctgaagccag
AMO-388..........gatccccgggtaccgagctcga
AMO-389..........CTATCTACCACTACCGCGCATggcgttctccta
AMO-421..........CTATCTACCACTACCGCGCATatgtatatct
AMO-428..........CTATCTACCACTACCCATggcgttctccta
AMO-429..........CTATCTACCACTACCGCGCTCCATggcgttctccta
AMO-430..........CTATCTACCACTACCGCGCTCATCCATggcgttct
ccta
AMO-431..........CTATCTACCACTACCGCGCTCATCACACATggc
gttctccta
AMO-432..........CTATCTACCACTACCGCGCATaatcttaaaatcggtg
AMO-557..........CTATCTACCACTACCGCGCATgtcaacccagctaat
AMO-569..........aggacctcgaggaaaagtagggttaagtaaacgggc
AMO-583..........gtcctggctcttccgcatctaccactaccgcgctc
AMO-617..........CTATCTACCACTACCGCGtttgtatagttcatc
AMO-659..........aaccaacatatggtgattcgtccttgtaaacc
AMO-660..........aaccaacccgggtcatggcttgactacctcc
AMO-661..........accaacatatggtgccaccattatcaaacacag
AMO-662..........aaccaacccgggttacctaacagaatcagttcttaagc
a Capital letters indicate patS minigene sequences.
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tained similar results (data not shown). Although the minigene
results fail to clearly identify the most likely candidate for the
genuine PatS signal, it is interesting that patS5 produced the
strongest heterocyst inhibition activity. Because the minigene
peptide products all contain at least one polar and one charged
amino acid and should be confined to the cytoplasm, these data
support a cytoplasmic location for the PatS receptor.
Expression of the patS5 minigene in proheterocysts failed to
inhibit multiple contiguous heterocysts in a patS null mutant.
To test the hypothesis that PatS-5 is confined to the cytoplasm,
we determined if the minigene product could function as a
cell-to-cell signal. The patS5 minigene was expressed from a
proheterocyst-specific promoter in the patS null mutant
AMC451 to determine if it could suppress the multiple-con-
tiguous-heterocyst (Mch) phenotype. Failure to suppress the
Mch phenotype would indicate that a cell-to-cell signal was not
being produced. The patS5 minigene was used in these exper-
iments because it produced the strongest heterocyst inhibition
(Table 3).
Expression of full-length patS and the patS5 minigene from
the rbcL promoter in constructs PrbcL-patS17 (pAM1690) (23)
and PrbcL-patS5 (pAM2537) completely inhibited heterocyst
formation in both the wild-type strain and the patS null mutant
AMC451 (Table 4). PrbcL is strongly expressed in vegetative
cells (7, 9). In BG-110 liquid medium, cultures of both strains
turned yellow within a few days and no heterocyst formation
was observed. These results show that PatS-5 pentapeptide can
completely block heterocyst differentiation when it is produced
in cells before they have become immune to PatS inhibition.
PpatS-patS5 (pAM2528) only partially inhibited heterocyst for-
mation in both strains (Table 4), reflecting the weak expression
of the patS promoter in vegetative cells (36, 37).
PhepA is expressed in developing proheterocysts and has
much lower expression in vegetative cells (14, 33, 39). Consis-
tent with previous results (36), PhepA-patS17 (pAM1715),
which contains the full-length patS gene, complemented the
patS deletion strain AMC451, suppressed the Mch phenotype,
and restored a nearly wild-type heterocyst pattern (Fig. 2;
Table 4). This shows that the hepA promoter is apparently
turned on strongly only after differentiating cells have become
immune to self-inhibition and shows that the wild-type PatS
product can function in cell-to-cell signaling to prevent the
formation of multiple contiguous heterocysts.
Expression of the patS5 minigene in differentiating cells
from PhepA-patS5 (pAM2814) did not suppress the Mch phe-
notype of AMC451 (Table 4). This result is consistent with the
pentapeptide failing to function in cell-to-cell signaling when
produced in proheterocysts. However, this construct may be
producing less PatS heterocyst inhibition activity because it did
not suppress heterocysts in the wild type. In an effort to mon-
itor the expression of PhepA-patS5, a promoterless gfp reporter
gene was placed downstream of the patS5 minigene such that
the gfp gene contained its own start codon and ribosome-
binding site. The PhepA-patS5-gfp construct (pAM2816) pro-
duced dim GFP fluorescence in differentiating cells, as ex-
pected, and had stronger heterocyst inhibition activity in the
wild-type background, which reduced the heterocyst frequency
to less than 1% (Table 4). The mechanism causing the stronger
heterocyst inhibition activity is unknown, but it might be due to
increased stability of the mRNA. In the presence of a wild-type
copy of patS, both PhepA-patS17 and PhepA-patS5-gfp produced
  8
PhepA-patS17
  patS
  0
  4
 12
 16
 20
0 4 8 12 16 >20 4 8 12 16 >20
PhepA-patS5-gfp
 patS
wild type
  4
  8
 12
 16
 20
 patS
Number of vegetative cells in the
interval between heterocysts
P
e
rc
e
n
ta
g
e
 o
f 
in
te
rv
a
ls
  0
A
C
B
D
FIG. 2. PatS-5 does not function as a cell-to-cell signal. Plasmids
containing patS17 and patS5 expressed from the proheterocyst-specific
promoter PhepA were used to complement the patS deletion strain
AMC451. The heterocyst pattern was determined 24 h after nitrogen
step-down for the wild type (A), strain AMC451 (B), AMC451 con-
taining pAM1715 (PhepA-patS17) (C), and AMC451 containing
pAM2816 (PhepA-patS5-gfp) (D).
TABLE 3. Suppression of heterocyst formation by PpetE-patS
minigenes in wild-type Anabaena strain PCC 7120 and the patS
mutant AMC451
patS minigene (plasmid)
Heterocyst frequencya (%)
Wild type AMC451
Cu2 Cu2 Cu2 Cu2
None (pAM504) 10.9 
 0.5 10.6 
 0.5 18.1 
 0.2 17.2 
 0.9
PpetE-patS4 (pAM2525) 11 
 0.2 10.6 
 0.5 16.4 
 1.7 16.9 
 0.7
PpetE-patS5 (pAM2424) 4.3 
 4.9 0.3 
 0.6 8.3 
 3.5 0.5 
 0.5
PpetE-patS6 (pAM2526) 1.8 
 1.3 0 
 0 12 
 3.6 6.7 
 4.7
PpetE-patS7 (pAM2529) 8.3 
 2.9 4.0 
 5.2 12 
 2.5 8.2 
 4.1
PpetE-patS8 (pAM2527) 4.0 
 5.2 0.2 
 0.3 12 
 2.5 2.2 
 1.8
a Frequencies measured 48 h after the nitrogen step-down. Results are pre-
sented as mean 
 standard deviation.
TABLE 4. Suppression of heterocyst formation by patS5 and patS17
in wild-type Anabaena strain PCC 7120 and the patS mutant
AMC451
patS minigene (plasmid)
Heterocyst frequencya (%) % of Mch
in
AMC451bWild type AMC451
None (pAM504) 12.2 
 2.0 19.9 
 2.1 11.5
PrbcL-patS5 (pAM2537) 0.0 
 0.0 0.0 
 0.0 0
PrbcL-patS17 (pAM1690) 0.0 
 0.0 0.0 
 0.0 0
PpatS-patS5 (pAM2528) 6.4 
 4.4 4.0 
 3.5 ND
c
PhepA-patS5 (pAM2814) 12.1 
 1.9 18.8 
 2.1 11.2
PhepA-patS17 (pAM1715) 0.0 
 0.0 9.8 
 0.2 0
PhepA-patS5-gfp (pAM2816) 0.7 
 1.0 18.8 
 1.9 12.3
a Frequencies measured 24 h after the nitrogen step-down. Results are pre-
sented as mean 
 standard deviation.
b The percentage of heterocysts that are multiple constitutive heterocysts
(Mch).
c ND, not determined.
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enough PatS heterocyst inhibition activity to overcome the
immunity to self-inhibition and blocked heterocyst differenti-
ation.
However, unlike the wild-type PatS produced from PhepA-
patS17, the PatS-5 pentapeptide produced from PhepA-patS5-
gfp failed to complement the patS deletion strain. AMC451
carrying PhepA-patS5-gfp had short vegetative-cell intervals and
formed multiple contiguous heterocysts (Fig. 2; Table 4).
These data show that the pentapeptide produced by the patS5
minigene expressed in proheterocysts cannot function in cell-
to-cell signaling and therefore is apparently confined to the
cytoplasm.
PatS-5 activity is not detectable in conditioned culture me-
dium. To determine if the patS5 minigene product was either
leaking or being transported out of filaments at concentrations
sufficient to inhibit heterocyst formation, we tested condi-
tioned culture supernatant from a strain containing PrbcL-patS5
(pAM2537) for heterocyst inhibition activity. The supernatant
from a culture of the strain grown in BG-110 medium failed to
inhibit heterocyst formation. In a reconstruction experiment to
verify that our assay could detect PatS-5 pentapeptide in con-
ditioned medium, we added synthetic PatS-5 to conditioned
culture supernatant and BG-110 medium at 0.1, 0.5, and 1 M.
Heterocyst formation was inhibited at each peptide concentra-
tion in both media. These results indicate that the patS5 mini-
gene product is not exported or does not leak from filaments at
concentrations capable of inhibiting heterocysts and are con-
sistent with the PatS signal interacting with a receptor in the
cytoplasm.
RGSGR fusion proteins inhibit heterocyst differentiation.
To further characterize the interaction between the PatS sig-
naling molecule and the PatS receptor, we tested PatS fusion
proteins for their ability to inhibit heterocyst formation. A
gfp-patS5 translational fusion was constructed and expressed
from the PrbcL promoter. The fusion of GFP to the N terminus
of PatS-5 should confine the RGSGR motif to the cytoplasm.
PrbcL-gfp-patS5 on pAM2873 completely inhibited heterocyst
formation after the nitrogen step-down and, as expected, pro-
duced strong GFP fluorescence in the cytoplasm of vegetative
cells (data not shown).
A six-histidine fusion at the C terminus of PatS produced
similar results. A translational fusion was constructed in
pAM2826 in which six histidine codons were added to the 3
end of the full-length patS ORF. When expressed from the
native patS promoter, patS-6His completely suppressed hetero-
cyst development. These results show that neither the N-ter-
minal GFP fusion nor the C-terminal His fusion interferes with
the ability of the RGSGR motif to interact with its receptor
and inhibit heterocyst differentiation. These results also are
consistent with the hypothesis that the PatS receptor is located
inside the cytoplasm of vegetative cells.
Proteins containing an RGSGR motif inhibit heterocyst dif-
ferentiation. We searched the Anabaena strain PCC 7120 ge-
nome for ORFs other than patS containing an RGSGR motif
to determine if overexpression of any of these ORFs was able
to inhibit heterocyst formation. The GeneMark program (4),
set to the lowest stringency, was used to identify all possible
ORFs in the Anabaena strain PCC 7120 genome (18). These
ORF sequences were then searched with a text editor for those
containing the RGSGR motif.
Four ORFs containing RGSGR were identified. One was
patS itself. Another was hetN, which is known to inhibit het-
erocyst development when overexpressed (3, 6). However,
HetN must have an independent heterocyst inhibition activity,
because site-directed mutation of the RGSGR motif in HetN
does not alter its heterocyst inhibition activity (24). The third
gene encoding a RGSGR motif was all3290, which encodes an
ortholog of an N. punctiforme protein annotated as the ATPase
component of an ABC-type sugar transport system. The fourth
RGSGR-encoding ORF was not documented in the annotated
Anabaena strain PCC 7120 genome database (18). This ORF
has only 77 codons and is located on the opposite strand from
the much larger ORF cyaC (all4963), which encodes an ade-
nylate cyclase (19). CyaC is a complex protein with motifs
similar to those of adenylate cyclases, response regulators, and
sensor kinases, and a cyaC mutant had much lower levels of
cyclic AMP than the wild type did. Thus, it seemed unlikely
that this short RGSGR-encoding ORF (termed orf77) is actu-
ally expressed; however, we tested both orf77 and all3290 for
heterocyst-inhibition activity.
ORFs all3290 and orf77 were cloned into the expression
vector pAM2770 downstream of the petE promoter, resulting
in pAM2918 and pAM2898, respectively. On BG-110 plates,
strains containing these constructs were completely suppressed
for heterocyst development. Although we assume that the
RGSGR motif is responsible for the inhibition, we cannot
exclude the possibility that these proteins inhibit heterocyst
differentiation by an unknown mechanism. Note that all3290
and orf77 in the wild-type chromosome normally must not
inhibit heterocyst formation, or they would mask the pheno-
type of patS mutants. From these experiments and those with
the patS fusion constructs, we conclude that the PatS receptor
is located in the cytoplasm and can interact with the RGSGR
motif embedded in different contexts. These conclusions are
consistent with the recent data indicating that the cytoplasmic
HetR protein may be the PatS receptor (15).
DISCUSSION
patS minigenes PpetE-patS5 to PpetE-patS8, but not PpetE-
patS4, on shuttle plasmids were able to inhibit heterocyst for-
mation. However, unlike the full-length patS gene, the patS5
minigene expressed from the heterocyst-specific promoter
PhepA did not complement the pattern formation defect of a
patS mutant. This result indicates that the PatS-5 pentapeptide
produced within differentiating cells by the minigene cannot
function in cell-to-cell signaling. Overall, overexpression of a
variety of genes encoding a RGSGR motif suppressed hetero-
cyst development, including patS itself, all3290, and orf77 and
patS fusion protein genes gfp-patS5 and patS-6His. Taken to-
gether, these results strongly support the hypothesis that the
PatS receptor is in the cytoplasm of cells and that the RGSGR
motif is capable of inhibiting heterocyst differentiation even
when embedded in different contexts.
PpetE-patS4 did not suppress heterocyst development in ei-
ther the wild type or the patS null mutant AMC451. Previous
work showed that the synthetic oligopeptide PatS-4 (GSGR)
had much less heterocyst inhibition activity than did PatS-5
when added to the growth medium (36). These results show
that PatS-4 cannot function as the PatS signal.
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When expressed from the copper-inducible petE promoter,
patS minigenes from patS5 to patS8 all inhibited heterocyst
development. The patS5 minigene appeared to produce the
strongest heterocyst inhibition, followed by patS6 and patS8;
patS7 showed the weakest inhibition activity in both the wild
type and the patS deletion strain AMC451. The basis for the
differences in biological activities among the patS minigenes is
unknown. Both full-length patS and the patS5 minigene
strongly suppressed heterocyst development when expressed in
vegetative cells under the control of PrbcL. The results of these
minigene experiments are consistent with the possibility that
the RGSGR pentapeptide may be the active signal molecule
controlling the heterocyst pattern. Our attempts to detect the
actual PatS signal molecule(s) by matrix-assisted laser desorp-
tion-ionization–time-of-flight mass spectrometry in wild-type
and patS overexpression strains compared to the patS deletion
mutant AMC451 have been unsuccessful thus far.
The patS5 minigene product cannot function in cell-to-cell
signaling. Unlike full-length patS, expression of the patS5 mini-
gene from the proheterocyst-specific PhepA promoter in
pAM2816 failed to complement the patS deletion mutant
AMC451 to produce a normal heterocyst pattern. pAM2816,
which carries PhepA-patS5 and a downstream gfp ORF, sup-
pressed heterocysts in the wild-type background, which indi-
cates that this construct produces levels of PatS-5 pentapeptide
sufficient to inhibit heterocysts. Since synthetic PatS-5 pen-
tapeptide can inhibit heterocysts when added exogenously to
filaments, the PatS-5 produced in proheterocysts from a mini-
gene must not be able to get out of the differentiating cells to
inhibit the neighboring cells. Because the full-length patS gene
functions cell nonautonomously and the patS5 minigene does
not, the C-terminal PatS-5 pentapeptide apparently lacks se-
quences required for cell-to-cell signaling.
The ability of ORF all3290 overexpression to inhibit hetero-
cyst development might be due to only the overexpression of
the RGSGR motif, or all3290 might be normally involved in
the regulation of heterocyst development. However, an all3290
knockout mutant grew normally and showed normal heterocyst
development and pattern formation (data not shown), indicat-
ing that it is not normally involved in heterocyst development.
Although RNA blot analysis showed that all3290 was ex-
pressed in filaments grown in nitrate-containing medium, tran-
scripts were undetectable after nitrogen step-down for 6, 12,
and 18 h (data not shown), when its expression might otherwise
have inhibited heterocyst differentiation. We conclude that the
RGSGR motif in all3290 does not normally regulate heterocyst
development but inhibits differentiation only when it is over-
expressed.
Because overexpression of a wide variety of RGSGR-encod-
ing genes suppressed heterocyst development, including patS,
all3290, orf77, gfp-patS5, patS-6His, and the patS minigenes
PpetE-patS5 to PpetE-patS8, the PatS receptor must be able to
interact with the RGSGR motif flanked by a variety of amino
acid sequences. This suggests that the PatS binding site on the
receptor is relatively open and accessible to the various
RGSGR-containing polypeptides. It is possible that some of
the PatS fusion proteins are degraded such that various smaller
peptides containing the RGSGR motif are produced. How-
ever, these putative peptides must still interact with the recep-
tor to inhibit the differentiation of heterocysts. Because all of
the RGSGR-fusion constructs and the ORFs containing an
RGSGR motif strongly inhibit heterocyst differentiation and
should be confined to the cytoplasm, the PatS receptor must be
located in the cytoplasm of vegetative cells, which is consistent
with PatS directly inhibiting HetR function. Together, the PatS
inhibitor and the HetR activator could satisfy the primary
requirements for regulation of the heterocyst pattern by lateral
inhibition, as recently proposed by Huang et al. (15). However,
other, more complex models of the regulation are possible, and
the true mechanism cannot be fully understood until the actual
molecule(s) that carries the inhibitory signal between cells has
been identified.
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